Skip to content
Last session
PDI $14.38 ▲2.86%D 3.0%DXYZ $28.88 ▼3.86%D 15.8%GOF $8.60 ▲1.44%D 13.7%VCX $25.44 ▲0.24%D 33.3%NEA $10.04 ▲2.53%D 1.8%PTY $10.82 ▲2.08%D 0.6%CLM $6.27 ▼0.61%D 1.4%NAD $10.32 ▲2.59%D 2.4%BCAT $13.14 ▼0.83%D 11.8%PDO $11.94 ▲1.88%D 2.2%JPC $6.80 ▲2.06%D 8.1%UTG $35.05 ▼1.04%D 5.0%BPRE $12.49 ▼0.48%D 46.9%NVG $10.83 ▲2.55%D 2.1%NZF $10.97 ▲2.88%D 1.4%BOT $26.18 ▼3.71%P 256.7%NMZ $9.11 ▲2.65%D 0.7%NAC $10.10 ▲2.74%D 2.1%CRF $5.93 ▼0.38%D 3.9%OXLC $8.36 ▲1.70%MQY $10.20 ▲3.01%D 7.2%RQI $11.15 ▲1.55%D 9.1%UTF $25.53 ▲0.04%D 3.3%ECAT $13.57 ▲0.63%HYT $7.74 ▲1.15%D 11.5%DNP $9.83 ▼0.25%P 6.4%NUV $8.23 ▲1.51%D 4.0%USA $5.98 ▲1.87%D 11.8%ADX $25.79 ▲0.55%D 4.1%DSL $9.78 ▲1.45%D 10.9%MHD $10.34 ▲2.47%D 9.3%TYG $38.43 ▼1.31%D 12.5%MUC $9.70 ▲1.29%D 8.6%MYI $9.78 ▲3.33%D 7.4%ASGI $19.33 ▲0.78%D 8.9%PHK $4.08 ▲1.49%D 4.2%JFR $7.32 ▲1.36%D 10.5%BSTZ $27.95 ▼0.56%EVV $8.35 ▲1.46%D 13.0%PCN $10.70 ▲1.90%D 1.8%

NHS

NYSE AmericanHigh Yield
Neuberger High Yield Strategies Fund
Sponsor: Neuberger Berman · Inception Jul 29, 2003 · Pays monthly
Market priceShare price
$5.35
+1.91% (+$0.10)
NAVAsset value per share
$6.21
as of Oct 13, 2026 · Nasdaq NAV symbol
Premium / discountPrice vs. assets
13.85% discount *
Indicative: latest price vs latest reported NAV
Distribution rate (price)Payout rate
20.30%
regular, annualised · on NAV 17.49%
Expense ratioAnnual cost
Not reported
no tagged fee table
LeverageBorrowing
Not reported
senior securities not tagged
Quote status: Market closed — last regular-session price · last trade Oct 15, 2026, 4:00 PM EDT (exchange time, ET) · retrieved Oct 15, 2026, 5:46 PM EDTRegular-session prices; extended-hours quotes are not displayed.
From the wire

News mentioning NHS

11 headlines
High Yield

Ondine shares backed by Peel Hunt as NHS ICU access expands

Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF) has won support from Peel Hunt after partnering with Mela Solutions to accelerate access for its Steriwave infection-prevention technology across NHS intensive care units. Peel Hunt retained its ‘buy' rating and 29p price target, highlig

Proactive Investors · Sep 29 · 05:56 UTC ↗
NHS · High Yield

Headlines link to the original publisher; the publisher’s own image is shown where the feed supplies one. Syndicated duplicates are collapsed. Activist or governance items are shown as filed positions or proposals, not as inferred intent.

CEF Explorer research page for Neuberger High Yield Strategies Fund Inc.. Figures carry their own dates and sources; a discount to NAV does not guarantee convergence or any return. This is not investment advice.